21 CFR § 314.235 Applications for FDA Approval to Market a New Drug

§ 314.235 Judicial review.

Current through Sep 8, 2026 · Read all of Part 314

⚠ 4 pending changes to Part 314

(a) The Commissioner of Food and Drugs will certify the transcript and record. In any case in which the Commissioner enters an order without a hearing under § 314.200(g), the record certified by the Commissioner is required to include the requests for hearing together with the data and information submitted and the Commissioner's findings and conclusion.

(b) A manufacturer or distributor of an identical, related, or similar drug product under § 310.6 may seek judicial review of an order withdrawing approval of a new drug application, whether or not a hearing has been held, in a United States court of appeals under section 505(h) of the act.

← § 314.201 Procedure for hearings.§ 314.410 Imports and exports of new drugs. →